Radiotherapy in the treatment of Langerhans cell histiocytosis

Tumor Diagnostik und Therapie

Volumn 21, Issue 5, 2000, Pages 96-102

  Belka, C ^a   Paulsen, F ^a   Becker, G ^a   Hoffmann, W ^b   Dopfer, R ^a   Bamberg, M ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b KLINIKUM BRAUNSCHWEIG   (Germany)

Author keywords

Bone; Diabetes insipidus; Langerhans cell histocytosis; Radiotherapy

Indexed keywords

ADULT; ARTICLE; BRAIN DISEASE; BRAIN TUMOR; CELLULAR DISTRIBUTION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES INSIPIDUS; ENDOCRINE DISEASE; FEMALE; HISTIOCYTOSIS X; HUMAN; MALE; MEGAVOLTAGE RADIATION; RADIATION DOSE; RELAPSE; TREATMENT OUTCOME; TREATMENT PLANNING; TUMOR GROWTH;

EID: 0033663834     PISSN: 0722219X     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2000-8380     Document Type: Article

References (36)

1. Langerhans cell histiocytosis
2. Treatment of Langerhans-cell histiocytosis in children. Experience at the Children's Hospital of Nancy
3. Histiocytosis X: Histologic arguments for a langerhans cell origin
4. Human epidermal Langerhans cells cointernalize by receptor-mediated endocytosis 'nonclassical' major histocompatibility complex class I molecules (T6 antigens) and class II molecules (HLA-DR antigens)
5. Clonal proliferation of Langerhans cells in Langerhans cell histiocytosis
6. Langerhans'-cell histiocytosis (histiocytosis X) - A clonal proliferative disease
7. Flow cytometric DNA analysis of lesions from 18 children with langerhans cell histiocytosis (histiocytosis x)
8. Expression of GM-CSF receptor by Langerhans' cell histiocytosis cells
9. Detection of GM-CSF in the sera of children with Langerhans' cell histiocytosis
10. Expression of cellular adhesion molecules in Langerhans cell histiocytosis and normal Langerhans cells
11. Splenomegaly in histiocytosis - Prognostic parameter or evidence of disease activity?
12. Bone lesions in histiocytosis X
13. Langerhans cell histiocytosis - Diagnosis, natural history, management and outcome
14. Intralesional infiltration of corticosteroids in localized Langerhans' cell histiocytosis
15. Radiation therapy in patients with histiocytosis: Management of diabetes insipidus and bone lesions
16. Radiation therapy of the eosinophilic granuloma
17. The role of radiation therapy in the management of children with histiocytosis X
18. Radiotherapy for eosinophilic granuloma of bone
19. Radiation therapy for diabetes insipidus caused by Langerhans' cell histiocytosis
20. Radiation therapy in soft-tissue lesions in histiocytosis X (Langerhans' cell histiocytosis)
21. Radiation therapy in the management of Langerhans cell histiocytosis
22. Eosinophilic granuloma: The management of solitary lesion of bone
23. LCH-l: A randomized trial of etoposide vs. vinblastine in disseminated Langerhans cell histiocytosis. (The Histiocyte Society)
24. Treatment strategy for disseminated Langerhans cell histiocytosis
25. Allogenic bone marrow transplatation for langerhans cell histiocytosis
26. Marrow transplantation for treatment of multisystem progressive Langerhans cell histiocytosis
27. Disease course and late sequelae of Langerhans' cell histiocytosis: 25-Year experience at the University of California, San Francisco
28. Anterior pituitary function and computed tomography/magnetic resonance imaging in patients with Langerhans cell histiocytosis and diabetes insipidus
29. Diabetes insipidus in Langerhans cell histiocytosis: Results from the DAL-HX 83 study
30. Chronic myelogenous leukemia following repeated radiation therapy for histiocytosis X
31. Acute leukemia in association with Langerhans cell histiocytosis
32. Histiocytosis X of the vulva
33. Langerhans cell histiocytosis: The case for conservative treatment
34. Spontaneous remission in histiocytosis X with lung and bone involvement
35. Spontaneous healing of Langerhans cell histiocytosis (histiocytosis X)